Acer Therapeutics Inc.
ACERDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069308
Acer Therapeutics Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 20, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $3.40M in total; no superinvestor held it.
Holders of 5% or more of ACER
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Acer Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Acer Therapeutics Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Acer Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2023 | TVM Life Science Ventures VI LP | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Nantahala Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Dec 2, 2022 | Schelling Chris | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Nantahala Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Nantahala Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Acer Therapeutics Inc. shares.
No Form 144 notices for Acer Therapeutics Inc. are on file.